Sign Out
Albutein is made from pooled human plasma. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases, including a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD). Although no cases of transmission of viral diseases or CJD have ever been identified for albumin, the risk of infectious agents cannot be totally eliminated. All infections thought by a physician possibly to have been transmitted by Albutein should be reported to the manufacturer at 1-323-225-9735. The physician should weigh the risks and benefits of the use of Albutein and should discuss these with the patient.
Albutein should not be used if they appear turbid or if there is sediment in the bottle. Do not begin administration >4 hrs after the container has been entered. Discard unused portion.
Albutein 20% and 25%: Following reports that there exists a risk of potentially fatal hemodialysis and acute renal failure from the inappropriate use of Sterile Water for Injection as a diluent for Albumin (Human), if dilution is required, acceptable diluents include 0.9% Sodium Chloride or 5% Dextrose in Water.
